Markets
Degenerate
@wsb
Bought JNJ
Shares
up 5.6%
At 143.1, Exited 151.2
I just bought shares in JNJ since the FDA's approval of their intranasal ketamine for depression is a major milestone. It’s opening new markets for th...
Read
More
Thesis
I just bought shares in JNJ since the FDA's approval of their intranasal ketamine for depression is a major milestone. It’s opening new markets for them, and I see potential for profit as their stock will likely rise with the increased interest in their treatments.
Go back
Posted
38d ago
6.44%
Scalped
•
Bearish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Stonks
@stocks
Bought JNJ
Shares
up 11.3%
At 146.1, Now 162.6
I just bought JNJ because it seems like the market is really overlooking its intrinsic value potential. With the models suggesting a price range signi...
Read
More
Thesis
I just bought JNJ because it seems like the market is really overlooking its intrinsic value potential. With the models suggesting a price range significantly higher than its current trading price, I believe there's a strong upside here for the long-term.
Go back
Long
@long_gam...
Bought JNJ
Shares
up 11.71%
At 145.5, Now 162.6
I'm considering a long position in JNJ, expecting a 7% increase year over year. With the stock currently low around $143 and the potential to hit $180...
Read
More
Thesis
I'm considering a long position in JNJ, expecting a 7% increase year over year. With the stock currently low around $143 and the potential to hit $180 or more in the coming years, it looks like a solid investment choice in the current state.
Go back
AtomicG
@atomicg
Bought JNJ
Calls
down -9.04%
At 0.98, Exited 0.9
Contract:
155 Strike Call for
Nov 22, 24
Thesis
Go back
Long
@long_gam...
Shorted JNJ
Shares
up 1.45%
At 160.7, Exited 158.3
I'm considering reducing my exposure to JNJ due to the recent drop in market value linked to penalties and the issues surrounding their baby powder. T...
Read
More
Thesis
I'm considering reducing my exposure to JNJ due to the recent drop in market value linked to penalties and the issues surrounding their baby powder. This stock may face further challenges in the near term, making it a candidate to reconsider in my portfolio.
Go back
Posted
129d ago
11.1%
Daytraded
•
Bearish
•
Exited
Hersh
@hersh
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Playing a little JNJ Earnings for tomorrow; not a huge bet so let's see if we can breach 160 into 155 below
Go back
Posted
140d ago
19.3%
Swung
•
Bearish
•
Exited
h
@szyharry...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Posted
142d ago
10.06%
Swung
•
Bullish
•
Exited
Lorenzo
@lorenzov...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Small bullish pennant formed on the hourly chart. Measured move takes it to 165 area.
Go back
CNBC
@cnbc
Bought JNJ
Shares
down -1.3%
At 164.2, Exited 162.1
I'm keeping an eye on JNJ after their latest bankruptcy filing. If their strategy to settle lawsuits gets court approval, it could provide a significa...
Read
More
Thesis
I'm keeping an eye on JNJ after their latest bankruptcy filing. If their strategy to settle lawsuits gets court approval, it could provide a significant turnaround for the stock, potentially driving prices up in the next few months. A win here could really help the company's value.
Go back
Long
@long_gam...
Bought JNJ
Shares
up 2.43%
At 158.5, Exited 162.3
With Johnson & Johnson nearing broad support for a $6.48 billion talc settlement, the resolution of this legal overhang could potentially lead to a po...
Read
More
Thesis
With Johnson & Johnson nearing broad support for a $6.48 billion talc settlement, the resolution of this legal overhang could potentially lead to a positive movement in JNJ's stock price, making it a strong buy candidate.
Go back
Lloyd
@lloyd-do...
Bought JNJ
Shares
up 2.48%
At 177.2, Now 162.6
Trims & Adds
[] Currently up $3.4K
[+] 73d ago
Added 100.52 shares @
149.23
[+] 164d ago
Added 89.62 shares @
167.38
[+] 262d ago
Added 101.49 shares @
147.80
[+] 353d ago
Added 93.77 shares @
159.97
[+] 1.2y ago
Added 94.61 shares @
158.55
[+] 1.5y ago
Added 93.73 shares @
160.03
[+] 1.7y ago
Added 94.63 shares @
158.52
[+] 2.0y ago
Added 98.06 shares @
152.96
[+] 2.2y ago
Initial 84.66 shares @
177.20
Thesis
Go back
Thomas
@thomas-c...
Bought JNJ
Shares
down -5.9%
At 172.8, Now 162.6
Thesis
Go back
Thomas
@thomas-t...
Bought JNJ
Shares
down -7.75%
At 161.3, Exited 148.8
Thesis
Go back
Jerry
@jerry-mo...
Bought JNJ
Shares
up 10.39%
At 147.3, Now 162.6
Thesis
Go back
Jerry
@jerry-mo...
Bought JNJ
Shares
up 9.54%
At 148.4, Now 162.6
Thesis
Go back
Jerry
@jerry-mo...
Bought JNJ
Shares
up 26.98%
At 128.0, Now 162.6
Thesis
Go back
Shelley
@shelley-...
Bought JNJ
Shares
up 14.23%
At 145.3, Now 162.6
Trims & Adds
[] Currently up $6.4K
[-] 2.3y ago
Trimmed 87.25 shares @
171.91
[+] 4.8y ago
Added 99.84 shares @
150.24
[+] 5.8y ago
Added 108.12 shares @
138.73
[+] 6.3y ago
Initial 103.23 shares @
145.30
Thesis
Go back
